These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9823969)
21. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. Aggerholm A; Grønbaek K; Guldberg P; Hokland P Eur J Haematol; 2000 Aug; 65(2):109-13. PubMed ID: 10966170 [TBL] [Abstract][Full Text] [Related]
22. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors. Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010 [TBL] [Abstract][Full Text] [Related]
23. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles. Kurose K; Bando K; Fukino K; Sugisaki Y; Araki T; Emi M Jpn J Cancer Res; 1998 Aug; 89(8):842-8. PubMed ID: 9765621 [TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719 [TBL] [Abstract][Full Text] [Related]
26. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396 [TBL] [Abstract][Full Text] [Related]
27. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859 [TBL] [Abstract][Full Text] [Related]
28. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833 [TBL] [Abstract][Full Text] [Related]
29. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer. Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923 [TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer. Su TH; Chang JG; Perng LI; Chang CP; Wei HJ; Wang NM; Tsai CH Gynecol Oncol; 2000 Feb; 76(2):193-9. PubMed ID: 10637069 [TBL] [Abstract][Full Text] [Related]
31. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947 [TBL] [Abstract][Full Text] [Related]
32. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Halachmi N; Halachmi S; Evron E; Cairns P; Okami K; Saji M; Westra WH; Zeiger MA; Jen J; Sidransky D Genes Chromosomes Cancer; 1998 Nov; 23(3):239-43. PubMed ID: 9790504 [TBL] [Abstract][Full Text] [Related]
33. The PTEN tumour suppressor gene and malignant melanoma. Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804 [TBL] [Abstract][Full Text] [Related]
34. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts. Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660 [TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions. Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263 [TBL] [Abstract][Full Text] [Related]
36. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Dahia PL; Aguiar RC; Alberta J; Kum JB; Caron S; Sill H; Marsh DJ; Ritz J; Freedman A; Stiles C; Eng C Hum Mol Genet; 1999 Feb; 8(2):185-93. PubMed ID: 9931326 [TBL] [Abstract][Full Text] [Related]
37. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792 [TBL] [Abstract][Full Text] [Related]
38. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover. Maehama T; Okahara F; Kanaho Y Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605 [TBL] [Abstract][Full Text] [Related]
39. PTEN mutations in malignant gliomas and their relation with meningeal gliomatosis. Izumoto S; Ohnishi T; Kanemura H; Arita N; Maruno M; Moriuchi T; Suzuki S; Yoshimine T J Neurooncol; 2001 May; 53(1):21-6. PubMed ID: 11678426 [TBL] [Abstract][Full Text] [Related]
40. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Nelen MR; van Staveren WC; Peeters EA; Hassel MB; Gorlin RJ; Hamm H; Lindboe CF; Fryns JP; Sijmons RH; Woods DG; Mariman EC; Padberg GW; Kremer H Hum Mol Genet; 1997 Aug; 6(8):1383-7. PubMed ID: 9259288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]